Aspen Aerogels (NYSE:ASPN) Price Target Lowered to $13.00 at Barclays

Aspen Aerogels (NYSE:ASPN) had its price objective reduced by Barclays from $25.00 to $13.00 in a research note released on Wednesday morning,Benzinga reports. They currently have an overweight rating on the construction company’s stock.

Other equities research analysts have also issued reports about the stock. Craig Hallum cut their price objective on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a report on Friday, February 14th. Piper Sandler reduced their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Roth Mkm dropped their price objective on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a report on Friday, February 14th. StockNews.com raised Aspen Aerogels to a “sell” rating in a report on Wednesday. Finally, Seaport Res Ptn lowered Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 12th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, Aspen Aerogels currently has a consensus rating of “Moderate Buy” and an average price target of $22.44.

Aspen Aerogels Stock Down 2.6 %

Shares of ASPN stock opened at $8.32 on Wednesday. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. Aspen Aerogels has a one year low of $8.25 and a one year high of $33.15. The company’s fifty day moving average price is $11.85 and its 200-day moving average price is $18.22. The company has a market capitalization of $682.38 million, a price-to-earnings ratio of 51.98 and a beta of 2.14.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. Sell-side analysts expect that Aspen Aerogels will post 0.46 EPS for the current fiscal year.

Institutional Investors Weigh In On Aspen Aerogels

Several large investors have recently added to or reduced their stakes in the stock. Quest Partners LLC boosted its holdings in shares of Aspen Aerogels by 263.3% in the third quarter. Quest Partners LLC now owns 7,397 shares of the construction company’s stock valued at $205,000 after purchasing an additional 5,361 shares during the period. Sandia Investment Management LP purchased a new stake in Aspen Aerogels during the fourth quarter worth $89,000. Pursue Wealth Partners LLC bought a new stake in Aspen Aerogels during the 3rd quarter valued at $222,000. Mesirow Financial Investment Management Inc. purchased a new position in shares of Aspen Aerogels in the 3rd quarter valued at $252,000. Finally, Kovitz Investment Group Partners LLC bought a new position in shares of Aspen Aerogels in the 3rd quarter worth $263,000. 97.64% of the stock is owned by institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.